Indeed, TRIM47 expression is higher in GBM and higher grade gliomas, correlating with poorer survival rates overall, although it is also reasonably well expressed in normal brain tissue (Uhlén et al., 2015; Ji et al., 2021). Here, TRIM47 is linked to central nervous system cancer.